To ascertain whether uterine shrinkage induced by a gonadotrophin releasing hormone agonist before hysterectomy for fibroids increases the possibility of a vaginal procedure.

Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial / P. Vercellini, P. G. Crosignani, C. Mangioni, E. Imparato, A. Ferrari, O. De Giorgi. - In: BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY. - ISSN 0306-5456. - 105:11(1998 Nov), pp. 1148-1154. [10.1111/j.1471-0528.1998.tb09967.x]

Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial

P. Vercellini
Primo
;
P.G. Crosignani
Secondo
;
1998-11

Abstract

To ascertain whether uterine shrinkage induced by a gonadotrophin releasing hormone agonist before hysterectomy for fibroids increases the possibility of a vaginal procedure.
Antineoplastic Agents, Hormonal; Leiomyomatosis; Triptorelin Pamoate; Combined Modality Therapy; Humans; Prospective Studies; Hysterectomy; Delayed-Action Preparations; Adult; Treatment Outcome; Uterine Neoplasms; Middle Aged; Female
Settore MED/40 - Ginecologia e Ostetricia
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/182223
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 43
  • ???jsp.display-item.citation.isi??? 26
social impact